Bharat Biotech unveils first vaccine candidate for Zika virus
Bharat Biotech claimed it began to work on the Zika Virus a year ago.
The company said it has invested over 150 million dollars since inception to build its portfolio of vaccines.
The most remarkable vaccine developments have been-
Rotavac - First vaccine from the developing world
Chikungunya Vaccine- entering Phase 1 trials shortly, first in the developing world.
Typbar TCV -Typhoid Conjugate Vaccine – successfully commercialized.
"The first thing is to be prepared for the worst," said Ella said who along with Sumathy and the R&D team at Bharat Biotech is working in the Zika vaccine program.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
